Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
From Bench to Bedside and Back: An Interview with Joshua Richter
5
Mins
June 2025
Joshua Richter – Associate Professor, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. What initially…
Read more
10
Mins
27 Jul 2021
Current and Future Therapies for β-Thalassaemia: A Review Article
β-thalassaemias are a clinically heterogenous group of inherited disorders caused by >200 described mutations in the β-globin gene, leading to a decreased or absent production of the β-globin chain.
5
Mins
27 Jul 2021
Recurrent Episodes of Angioedema Consistent with Polycythaemia Vera
Polycythaemia vera (PV) is a condition characterised by an increasing number of the red blood cells in the blood.
4
Mins
27 Jul 2021
Glanzmann Thrombasthenia: A Case Report
Eduard Glanzmann first reported Glanzmann thrombasthenia (GT) in 1918 after he identified a functional abnormality of platelets with defective clot retraction.
9
Mins
23 Jun 2021
FLT3 Mutations in Patients with Acute Myeloid Leukaemia: The Importance of Identification and Monitoring for Prognostic Determination and the Selection of Optimal Treatment Strategies
Mutations in FLT3 are the most common genetic alteration in AML. Patients with a FLT3 internal tandem duplication (ITD) mutation subtype have poor prognosis, especially when there is a high allelic burden.
9
Mins
17 Jun 2021
Pre-transplant Determinants of Outcome in Patients with Myeloma
Multiple myeloma is a malignant neoplasm arising from clonal proliferation of plasma cells in the bone marrow…
9
Mins
17 Jun 2021
New Therapeutic Approaches for Acute Myeloid Leukaemia
Acute myeloid leukaemia (AML) is a life-threatening, multifactorial haematological neoplasm characterised by the accumulation of transformed immature myeloid progenitors…
9
Mins
19 May 2021
The Search for New Therapies for Patients with Myelodysplastic Syndrome: Exploring the Immune and Inflammatory Microenvironments
This symposium took place virtually at the European School of Haematology (ESH) 7th Translational Research e-Conference: Myelodysplastic Syndromes (MDS)…
5
Mins
19 Apr 2021
Rifampicin-Induced Thrombocytopenia
Thrombocytopenia is generally defined as a platelet count below the lower normal limit, <150×109/L, although many suggest that a cut-off value…
Loading posts...
« Previous
1
…
6
7
8
9
10
…
23
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View